BCL2 and Parkinson disease: The Bax/Bcl-2 ratio in Rotenone group was considerably higher (p < 0.01) than the control group, and lower in the OLE-treated PD mice (p < 0.01; Fig. 9B), demonstrating the antiapoptotic function of OLE in the parkinsonian mouse model.